Navigation Links
Oxford Finance Closes $25 Million Senior Credit Facility with Entellus Medical
Date:1/8/2014

ALEXANDRIA, Va., Jan. 8, 2014 /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced that it entered into a term loan agreement with Entellus Medical, Inc. that expanded the original $17 million loan facility to $25 million. Entellus is using proceeds of the loan to support business operations and the ongoing marketing efforts for its minimally invasive treatments for chronic sinusitis.

"Entellus has impressed the medical community with its quality solutions for treating patients with sinusitis," said Christopher A. Herr, managing director for Oxford Finance. "We are pleased to provide financial support to the company as it continues to grow revenues and increase market share."

"Oxford has been a valued and reliable financial partner for Entellus," said Thomas E. Griffin, chief financial officer for Entellus Medical. "They understand our industry and support our primary business goal, which is to bring highly efficacious and cost-saving sinusitis treatments to patients in the convenience of the doctor's office."

About Oxford Finance LLC

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life science and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $2 billion in loans, with lines of credit ranging from $500 thousand to $50 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Illinois, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.  

About Entellus Medical, Inc.

Entellus Medical provides complete solutions for the minimally invasive treatment of chronic and recurrent sinusitis patients and is leading the way with easy-to-use, cost-effective products designed for office-based balloon dilation of narrowed sinus pathways. With this approach, Entellus sinus dilation products also provide significant efficiency and cost-effectiveness for sinus dilation procedures performed in operating rooms. For more information on XprESS™ Multi-Sinus Dilation Tool, FinESS™ Sinus Treatment, or PathAssist™ sinus confirmation tools visit www.EntellusMedical.com.


'/>"/>
SOURCE Oxford Finance LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
2. Senate Finance Committee Addresses Problem-Plagued Medicare Bidding Program in SGR Bill
3. Genpact and AstraZeneca Extend Finance and Accounting Services Agreement
4. Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development
5. Regeneron Announces Appointment of Robert E. Landry as Senior Vice President, Finance and Chief Financial Officer
6. Michael A. Jacobsen Joining Omeros as Vice President, Finance and Chief Accounting Officer
7. Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities
8. Horizon Technology Finance Closes $2 Million Venture Loan Facility with New Haven Pharmaceuticals
9. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
10. Invuity Bolsters Executive Team; Adds Industry Veterans in Key Finance and Commercial Roles
11. McGuireWoods and McGladrey Present 10th Annual Healthcare and Life Sciences Private Equity and Finance Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... focused on the development of oral drug delivery systems, ... with the U.S. Food and Drug Administration (FDA) regarding ... At the meeting, the FDA ... of ORMD-0801, would be a Biologics License Application (BLA).  ...
(Date:9/1/2017)... -- Bayer will present the latest research from across its growing ... 2017 Congress, September 8-12 in Madrid, Spain ... data on Bayer,s marketed portfolio and late-stage compounds as well ... "We value the opportunity to meet ... ESMO," said Carsten Brunn , Head of Pharmaceuticals, Americas ...
(Date:8/29/2017)... In a move that promises to exponentially ... veterinary practices of all sizes, Cubex LLC and The ... TITAN,s expertise in physical security, drug diversion investigations, staff ... "Every veterinary ... is at risk today," said TITAN founder and CEO, ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... Happy Living’s mission - to improve ... carries it into the entertaining and delicious worlds of theatre and wines. , ... Living) convinced him to turn his play into a book. The Greener The Grass ...
(Date:9/22/2017)... ... September 22, 2017 , ... "Success ... the world of Alzheimer’s. Alzheimer’s is a disease estimated to affect the lives ... information published by the Alzheimer’s Association, a leading voice in the fight for ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg freezing ... Although frozen embryos have a slight statistical advantage for live births, frozen eggs ... wonderful opportunity for women undergoing medical treatment or who are concerned about the ...
(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal safety ... the end of November. , The Chicago, Illinois, based self-defense brand has been waiting ... about the ease of taking their personal safety into their own hands. , The ...
(Date:9/21/2017)... San Diego, Ca (PRWEB) , ... September 21, 2017 , ... ... and affordable services to its customers, and give back to the community. For over ... on of the most successful companies serving plumbing in San Diego. They ...
Breaking Medicine News(10 mins):